Diabetic Retinopathy and Calcium Dobesilate Baltimore MD

Read more about Diabetic Retinopathy and Calcium Dobesilate.

Marcia S Driscoll, MD
(410) 328-5823
419 W Redwood St
Baltimore, MD
Business
University of Maryland Dermatology
Specialties
Dermatology

Data Provided by:
Hampden Family Chiropractic
(443) 478-2892
3617 Falls Road
Baltimore, MD

Data Provided by:
Multi Specialty Healthcare
(410) 234-1600
1800 N Charles St
Baltimore, MD

Data Provided by:
Sajeev Kathuria, MD
(410) 328-6533
419 W Redwood St
Baltimore, MD
Business
University of Maryland Eye Associates
Specialties
Ophthalmology

Data Provided by:
Camden-Inner Harbor Veterinary Services
(410) 404-1600
Camden Yards - Baltimore
Baltimore, MD

Data Provided by:
Sheri Rowen, M.D. Laser Vision Correction
(410) 332-9500
301 Saint Paul Pl
Baltimore, MD

Data Provided by:
Tom Ingegno M.S.O.M., L.Ac.
(410) 842-7784
715 Park Ave
Baltimore, MD
Business
Ancient Arts Acupuncture
Specialties
Acupuncture
Insurance
Insurance Plans Accepted: Blue Cross/ Blue ShieldCare FirstFederal Blue Cross/ Blue ShieldCignaUnited HealthcareAetnaMail Carriers
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: Yes
Emergency Care: No

Doctor Information
Medical School: NY College of Wholistic Health Education & Research, 2001
Additional Information
Member Organizations: NAJOM, NCCAOM, ASNY, Maryland Acupuncture Society.
Languages Spoken: English

Data Provided by:
Chengzhang Shi
(410) 905-7140
711 W. 40th St.
Baltimore, MD
Business
Cheng's Acupuncture & Herbs Clinic
Specialties
Acupuncture
Insurance
Insurance Plans Accepted: BlueCross BlueShield, EHP, United Health care, PhCS, EHP, Anthem, PHN, Kaiser
Workmens Comp Accepted: Yes
Accepts Uninsured Patients: Yes
Emergency Care: No

Doctor Information
Medical School: Union Peking Medical School/MITCM, 90/02
Additional Information
Languages Spoken: English,Chinese

Data Provided by:
Bernard Chang
(410) 332-9700
301 St. Paul Place
Baltimore, MD
Specialties
Cosmetic Surgery
Insurance
Medicare Accepted: No
Workmens Comp Accepted: No
Accepts Uninsured Patients: No
Emergency Care: No


Data Provided by:
DocSide Veterinary Medical Center
(410) 522-0055
1705 Bank St
Baltimore, MD

Data Provided by:
Data Provided by:

Diabetic Retinopathy and Calcium Dobesilate

Diabetic Retinopathy and Calcium Dobesilate.
Date: Wednesday, May 27, 2009
Source: The Lancet
Related Monographs: Diabetes Mellitus, Type 2
Natural Health Information that is accurate, objective, science-based and represents the current state of research is the most sought-after information category today. Natural Health Information On Demand, NHIOndemand, is the leading source for this valuable science-based natural health information.
©2000-2009 CCG, Inc. All Rights Reserved.

Diabetic retinopathy is retinopathy (damage to the retina) caused by complications of diabetes mellitus, which can eventually lead to blindness.  It is the most common diabetic eye disease and affects up to 80% of all patients who have had diabetes for 10 years or more. Small blood vessels - such as those in the eye - are especially vulnerable to poor blood sugar (blood glucose) control which could cause an over accumulation of glucose and/or fructose damaging the tiny blood vessels in the retina. During the initial stage, called nonproliferative diabetic retinopathy (NPDR), most people do not notice any change in their vision. In the United States, diabetic retinopathy is the leading cause of blindness in adults. All people with diabetes mellitus are at risk - those with type 1 diabetes (juvenile onset) and those with type 2 diabetes (adult onset). Between 40 to 45 percent of Americans diagnosed with diabetes have some stage of diabetic retinopathy.

Calcium dobesilate, also known as 2,5-dihydroxybenzene sulfonate, is a drug commonly used in the treatment of diabetic retinopathy and chronic venous insufficiency. The pharmacology of calcium dobesilate reveals its ability to decrease capillary permeability, as well as platelet aggregation (clumping together of platelets) and blood viscosity (a measure of the resistance of blood to flow).

A multi-center randomized, double-blind and placebo controlled study assessed the effect of calcium dobesilate on the occurrence of diabetic macular edema. The study, which took place in 40 different centers in 11 countries, enrolled 635 patients with type 2 diabetes and mild-to-moderate non-proliferative diabetic retinopathy. The patients were then randomly selected to receive either calcium dobesilate or a placebo. Clinically significant macular edema (CSME) developed in 86 of the 324 people who took calcium dobesilate and in 69 of the 311 who took the placebo. It was determined that people who took the drug were 32 percent more likely to develop CSME than those who took the placebo. This information suggests that calcium dobesilate could neither prevent the occurrence of macular edema nor reduce the probability of developing it. The researchers concluded that the best way to prevent diabetic blindness is by implementing systemic screenings for diabetic retinopathy and preventive laser treatment for those who develop macular edema or proliferative retinopathy.1  

1 Haritoglou C, Gerss J, Sauerland C, et al. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial. The Lancet. 2009;373(9672):1364-1371.

This information is educational in context and is not to be used to diagnose, treat or cure any disease. Please consult your licensed health care practitioner before using this or any medical information.
©2000-2009 CCG, Inc. All Rights Reserved.